PTI News and Press, Yumanity Therapeutics Inc Com From 11/24/19

The NASDAQ Biotechnology Index (INDEXNASDAQ: NBI ) was on the steady incline last week, rising from just over 3,500 points on Monday’s (November 18) open to 3,624.20 points as of 2:24 p.m. EST on Friday (November 22). Over the course of the week, CRISPR Therapeutics (NASDAQ: CRSP ) an...

Gainers:  EyeGate Pharmaceuticals (NASDAQ: EYEG ) +43% . More news on: EyeGate Pharmaceuticals, Inc., Stage Stores, Inc., Cancer Genetics, Inc., Stocks on the move, Read more ...

Proteostasis Therapeutics (PTI) is a biotech that should be on everyone's radar. That's because there are a few catalysts that are approaching in Q4 of 2019. Phase 1 results were released for PTI's doublet and triplet combination back in March of 2019. Investors put emphasis and focus on the...

Proteostasis Therapeutics (NASDAQ: PTI ): Q3 GAAP EPS of -$0.25 beats by $0.15 . More news on: Proteostasis Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

BOSTON , Nov. 7, 2019 /PRNewswire/ -- Proteostasis Therapeutics, Inc. (NASDAQ:PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF) and other diseases caused by dysfunctional protein processing...

As the global population continues to get older, the widespread popularity of anti-aging products also continues to rise thanks to advancements in technology  and an increase in demand for anti-aging skincare products. The world’s population is always growing older, and the need...

BOSTON , Nov. 6, 2019 /PRNewswire/ -- Proteostasis Therapeutics, Inc. (NASDAQ: PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF), today announced completion of enrollment in the Compan...

Noteworthy events during the week of October 27 - November 2 for healthcare investors. More news on: AMAG Pharmaceuticals, Inc., Agile Therapeutics, Inc., Adamas Pharmaceuticals, Inc., Healthcare stocks news, , Read more ...

BOSTON , Oct. 24, 2019 /PRNewswire/ -- Proteostasis Therapeutics, Inc. (NASDAQ:PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF) and other diseases caused by dysfunctional protein proc...

BOSTON , Oct. 21, 2019 /PRNewswire/ -- Proteostasis Therapeutics, Inc. (NASDAQ:PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF) and other diseases caused by dysfunctional protein processin...